Figure S2 from Evaluation of the Role of AXL in Fusion-positive Pediatric Rhabdomyosarcoma Identifies the Small-molecule Inhibitor Bemcentinib (BGB324) as Potent Chemosensitizer

Authors:

Open Access

Publisher website

17 June 2026

other
Published by American Association for Cancer Research (AACR)

DOI:10.1158/1535-7163.32711324

Abstract

AXL genetic removal and pathway activation.

Keywords